Nordic Nanovector ASA (DE:8NN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Thor Medical ASA, an emerging supplier of alpha-emitters for precision cancer treatment, reported steady progress on their pilot facilities and initiated a concept study for a fast-track plant aimed at meeting the growing demand for radiotherapeutics. Despite no revenues and a loss of NOK 13.1 million in the first half of 2024, the company is fully funded through the first half of 2025, with a cash reserve of NOK 29.6 million. The company is advancing towards commercial production with a focus on thorium-derived isotopes, addressing a potential multi-billion USD market.
For further insights into DE:8NN stock, check out TipRanks’ Stock Analysis page.
